NTF6A

Across TCGA pan-cancer cohorts, NTF6A RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated NTF6A data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher NTF6A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NTF6A expression acts as an unfavorable survival marker.

OV, KIRC, and STAD are the cancer types where NTF6A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.545	0.701	<.001	102	view →
KIRC	DFS	Tertile	IV	0.261	0.652	<.001	90	view →
STAD	DFS	Tertile	All	0.292	0.726	<.001	72	view →
UCS	OS	Tertile	All	0.205	0.695	.007	54	view →
MESO	OS	Tertile	All	0.144	0.557	.029	45	view →
PRAD	OS	Tertile	All	0.847	0.990	<.001	36	view →
LUSC	OS	Tertile	All	0.309	0.732	.009	27	view →
GBM	OS	Tertile	All	0.030	0.416	<.001	18	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
BRCA	DFS	Tertile	III,IV	0.381	0.800	<.001	18	view →
SKCM	DFS	Tertile	III,IV	0.247	0.664	.003	15	view →
TGCT	DFS	Tertile	II,III,IV	0.679	0.953	.034	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

NTF6A–OV (OS)

Open the OV breakdown →